• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Liquidia Corporation - Common Stock (NQ:LQDA)

    59.24 +1.65 (+2.87%)
    Streaming Delayed Price Updated: 12:20 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Liquidia Corporation - Common Stock

    < Previous 1 2 3 4 Next >
    News headline image
    Liquidia Corporation Reports First Quarter 2026 Financial Results
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Participate in Upcoming Investor Conferences
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Participate in Upcoming Investor Conferences
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
    From Liquidia Technologies, Inc.
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
    From Liquidia Corporation
    Via GlobeNewswire
    News headline image
    Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
    FDA sets PDUFA goal date of May 24, 2025 
    From Liquidia Corporation
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.